Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)

Scientific and grants management contacts by research area

Peer review contact:
Yujing Liu, MD, PhD
301.402.1366
liuyujin@mail.nih.gov

The purpose of this opportunity is to stimulate a partnership of ideas and technologies between small business concerns and nonprofit research institutions resulting in improving minority health and the reduction of health disparities. Funding should be used to develop products, processes, and services that can be used to improve minority health and/or reduce and ultimately eliminate health disparities in one or more NIH-defined health disparity population groups. Technologies should be effective, affordable, and culturally acceptable.

NIH health disparity populations include:

• Racial and ethnic minorities
• People with lower socioeconomic status
• Underserved rural communities
• Sexual/gender minorities
• People with disabilities

Technologies are also needed to assist in overcoming the social determinants of health (SDOH) and various barriers, including but not limited to:

• Physical Barriers – Factors such as proximity to healthcare facilities and transportation that limit access to healthcare
• Knowledge Barriers - Health literacy and language barriers that inhibit healthcare delivery, as well as a lack of patient information for healthcare providers
• Infrastructure Barriers - Limited access to resources, expertise, and advanced medical technologies for rural hospitals and community health centers
• Economic Barriers - Disparities in healthcare access caused by lack of insurance coverage and/or financial resources
• Cultural Barriers - Cultural beliefs, practices, procedures, and policies shared among the members of social groups, including racial/ethnic populations, communities, healthcare organizations, institutions, and facilities, that impede access to healthcare, health promoting activities, or health promoting technologies

Detailed lists of research objectives and specific areas of research interest are provided in the application instructions.

Small business concerns (SBCs) in the United States are eligible to apply.

Award ceiling: $306,872 for Phase I awards and $2,045,816 for Phase II awards
Project period: 1 year for Phase I and up to 2 years for Phase II
Estimated total program funding and number of awards: Based on research area and NIH Component

Links to the full announcement and the online application process are available through grants.gov.

While not required, potential applicants are encouraged to email a letter of intent to Yujing Liu, MD, PhD at least 30 days prior to the application due date.

This opportunity expires on December 10, 2026.